Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis-Reference-Cited by-同舟云学术

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

Published:2013-04-17 Issue:9 Volume:105 Page:595-605
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Lee Chee Khoon,Brown Chris,Gralla Richard J.,Hirsh Vera,Thongprasert Sumitra,Tsai Chun-Ming,Tan Eng Huat,Ho James Chung-Man,Chu Da Tong,Zaatar Adel,Osorio Sanchez Jemela Anne,Vu Vu Van,Au Joseph Siu Kie,Inoue Akira,Lee Siow Ming,Gebski Val,Yang James Chih-Hsin

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/9/595/17313169/djt072.pdf

Reference57 articles.

1. A translational view of the molecular pathogenesis of lung cancer;Sato;J Thorac Oncol,2007

2. Lung cancer in never smokers—a different disease;Sun;Nat Rev Cancer,2007

3. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients;Tang;Cancer Res,2005

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 436 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression;Medicina;2024-08-06

2. Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy;JMIR Research Protocols;2024-07-02

3. T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1;Biochemistry and Biophysics Reports;2024-07

4. EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report;Anti-Cancer Drugs;2024-03-15

5. Clinical Results and Hematologic Predictors of Linear Accelerator–Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective Study;World Neurosurgery;2024-03